Fused Tricyclic Kinase Modulators for CK2 Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current molecules fail to effectively inhibit cell proliferation and modulate serine-threonine protein kinase activity, particularly casein kinase 2 (CK2), which is crucial for regulating various biological processes including angiogenesis and apoptosis.
Innovation Solution
Development of chemical compounds with a specific fused tricyclic ring system that inhibit CK2 activity, inhibit angiogenesis, and induce apoptosis, while also being effective in modulating protein kinase activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current molecules are used, then cell proliferation inhibition and protein kinase modulation are insufficient, but using novel fused tricyclic ring compounds increases molecular complexity
Solution Approach 1:
The molecule is divided into distinct functional segments: a fused tricyclic ring system (comprising a first ring, second ring, and third ring), a linker moiety, and a substituent group. This segmentation allows each portion to contribute specifically to CK2 binding and inhibition, with the tricyclic system providing structural rigidity and the linker enabling flexible interaction with the kinase active site.
Solution Approach 2:
The compound combines multiple structural components (fused aromatic rings, heteroatoms, linker groups) into a composite molecular architecture that synergistically enhances CK2 inhibition. The fused tricyclic ring system integrates electron-rich aromatic rings with heteroatoms to create a composite structure with optimized electronic and steric properties for potent and selective kinase modulation.
2Reliability
If novel fused tricyclic ring compounds are developed, then CK2 modulation and anti-proliferation effects improve, but synthesis complexity and manufacturing difficulty increase
Solution Approach 1:
The fused tricyclic ring system is constructed as a pre-assembled core structure before final coupling with the linker and substituent. This preliminary formation of the rigid aromatic core simplifies subsequent synthesis steps, as the complex polycyclic framework is established once and then functionalized with smaller moieties in straightforward reactions.
3Reliability
If the group attached to Q1 is connected through a heteroatom, then previous compounds showed limited activity, but the invention discovers direct attachment provides unexpectedly beneficial results
Solution Approach 1:
Instead of attaching the substituent through a heteroatom as in previous compounds, the invention inverts the attachment strategy by using direct carbon-to-carbon bonding between the tricyclic ring system and the substituent group. This inversion of the linkage mode eliminates the heteroatom intermediary, creating a more rigid and electronically distinct connection that unexpectedly enhances CK2 inhibition and biological activity.
Data Source
AI summary
The invention relates in part to molecules having certain biological activities that include, but are not limited to, inhibiting cell proliferation, and modulating protein kinase activity. Molecules of the invention can modulate casein kinase (CK) activity. The invention also relates in part to methods for using such molecules.